Grufity logoGrufity logo

DGX

148.92USD-1.54(-1.02%)Market Closed

Quest Diagnostics Inc

Market Summary

USD148.92-1.54Market Closed
-1.02%

DGX Alerts

DGX Stock Price

RSI Chart

Valuation

Market Cap

16.9B

Price/Earnings

13.7

Price/Sales

1.64

Price/Cashflow

9.07

MarketCap/EBT

10.39

Price/Sales

Profitability

Operating Margin

35.95%

EBT Margin

15.82%

Return on Equity

19.69%

Return on Assets

9.34%

Fundamentals

Revenue

Revenue (TTM)

10.3B

Revenue Y/Y

-10.38%

Revenue Q/Q

1.35%

Earnings

Earnings (TTM)

1.2B

Earnings Y/Y

-49.31%

Earnings Q/Q

9.4%

Price Action

52 Week Range

119.75170.79
(Low)(High)

Last 7 days

-0.1%

Last 30 days

3.7%

Last 90 days

19.4%

Trailing 12 Months

-3.3%

Financial Health

Current Ratio

1.46

Debt/Equity

0.63

Debt/Cashflow

0.47

Investor Care

Dividend Yield

1.45%

Buy Backs (1Y)

6.40%

Diluted EPS (TTM)

10.19

Peers (Alternatives to Quest Diagnostics)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
64.2B
59.8B
11.06% 3.05%
9.86
1.07
3.14% -18.15%
20.3B
15.3B
3.99% -17.87%
10.19
1.29
-7.83% -36.44%
16.9B
10.3B
3.69% -3.31%
13.7
1.64
-6.81% -43.45%
MID-CAP
8.6B
13.2B
13.64% 4.85%
11.12
0.66
6.21% -30.27%
5.5B
5.5B
6.72% 8.90%
11.91
1.05
68.51% 117.01%
5.5B
5.1B
5.38% 25.05%
16.63
1.03
1.10% -32.81%
5.2B
2.3B
-2.26% 45.46%
54.18
2.25
7.63% -28.34%
5.0B
2.9B
0.50% 21.52%
23.43
1.72
13.49% 10.78%
4.9B
408.1M
9.90% -42.72%
-9.19
11.99
26.10% -44.06%
3.2B
2.2B
4.67% -33.60%
26.22
1.43
0.68% -45.06%
SMALL-CAP
1.1B
1.4B
24.85% -22.07%
47.05
0.81
6.94% -77.50%
849.9M
2.8B
-23.39% -42.51%
-9.25
0.32
-6.67% -377.23%
105.7M
111.6M
-14.16% -43.71%
-16.12
0.95
-0.75% -611.70%
41.6M
46.8M
4.29% -74.04%
-1.1
0.94
-3.12% -66.57%
36.2M
26.0M
-12.21% -18.86%
-30.63
1.38
9.09% -588.38%

Financials for Quest Diagnostics

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-2.7%10,29410,58210,67910,78811,046
Cost Of Revenue-0.8%6,5936,6456,5996,5796,594
  S&GA Expenses2.1%1,7751,7381,7451,7271,710
Earnings Before Taxes-15.7%1,6281,9312,4252,5992,855
Net Income-16.8%1,2351,4841,8811,9952,184
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-0.7%13,22313,31213,44213,61113,572
  Current Assets-3.8%2,3342,4262,4752,7412,854
    Cash Equivalents-11.4%700790712872987
  Inventory-2.1%183187197208205
  Net PPE2.6%1,7071,6641,6681,7071,634
  Goodwill-0.1%7,1907,1957,1977,0957,057
  Current Liabilities1.6%1,6021,5771,7001,7531,759
  Long Term Debt-0.1%3,9803,9833,9854,0104,006
    LT Debt, Current0%22221
Shareholder's Equity-2.2%6,2726,4116,3776,4446,392
  Retained Earnings2.2%8,2638,0837,9267,6497,333
  Additional Paid-In Capital1.1%2,2502,2262,2601,936-
Shares Outstanding-1.7%117119123--
Minority Interest-5.1%3739383940
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-3.1%1,8651,9241,9822,2332,293
  Share Based Compensation-3.9%7477797994
Cashflow From Investing-3.8%-596.00-574.00-55.002180
Cashflow From Financing-38.9%-1,556.00-1,120.00-2,445.00-2,540.00-2,991.00
  Dividend Payments-1.0%305308309307
  Buy Backs43.4%1,2368622,1622,1992,160

Risks

What is the probability of a big loss on DGX?

56.9%


Probability that Quest Diagnostics stock will be more than 20% underwater in next one year

19.2%


Probability that Quest Diagnostics stock will be more than 30% underwater in next one year.

0%


Probability that Quest Diagnostics stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DGX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Quest Diagnostics was unfortunately bought at previous high price.

Returns

Cumulative Returns on DGX

12.1%


10-Year Cumulative Returns

13.9%


7-Year Cumulative Returns

11.1%


5-Year Cumulative Returns

13.9%


3-Year Cumulative Returns

What are the long-term rolling returns for DGX?

FIve years rolling returns for Quest Diagnostics.

Which funds bought or sold DGX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
Bridgefront Capital, LLC
SOLD OFF
-100
-584,000
-
-%
2022-11-23
Eagle Bay Advisors LLC
ADDED
4.84
-1,676
45,000
0.03%
2022-11-23
Aurora Investment Counsel
REDUCED
-49.58
-2,095,000
1,774,000
1.35%
2022-11-23
Toroso Investments, LLC
ADDED
10.74
25,000
1,555,000
0.06%
2022-11-23
Gould Capital, LLC
UNCHANGED
-
-1,000
17,000
0.01%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
1,333,000
1,333,000
0.02%
2022-11-22
National Asset Management, Inc.
SOLD OFF
-100
-233,000
-
-%
2022-11-22
CVA Family Office, LLC
SOLD OFF
-100
-6,000
-
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-2.2
-2,600,000
24,014,000
0.04%
2022-11-21
FourThought Financial, LLC
UNCHANGED
-
-
1,000
-%

1–10 of 47

Latest Funds Activity

Are funds buying DGX calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own DGX

Quest Diagnostics News

Marketscreener.com

Bread of Life, Inc. Teams Up With the Quest Diagnostics Foundation and Local Community Partners To Improve Access to Healthcare and Create Job Opportunities for Underserved Communities.2 hours ago

DGX Fair Value

Recent SEC filings of Quest Diagnostics

View All Filings
Date Filed Form Type Document
Nov 29, 2022
4
Insider Trading
Nov 22, 2022
3
Insider Trading
Nov 22, 2022
3
Insider Trading
Nov 22, 2022
3
Insider Trading
Nov 22, 2022
3
Insider Trading
Nov 18, 2022
8-K
Current Report
Nov 03, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 01, 2022
8-K
Current Report
Oct 28, 2022
8-K
Current Report

Latest Insider Trading transactions for DGX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-28
Doherty Catherine T.
SOLD
-6,081,260
149.179
-40,765
SVP, Regional Businesses
2022-11-28
Doherty Catherine T.
ACQUIRED
3,531,470
86.63
40,765
SVP, Regional Businesses
2022-11-01
RING TIMOTHY M
ACQUIRED
122,136
61.0682
2,000
-
2022-11-01
Davis J. E.
ACQUIRED
-
-
13,980
CEO and President
2022-11-01
RING TIMOTHY M
SOLD
-288,120
144.06
-2,000
-
2022-10-26
DEPPE MICHAEL J
SOLD
-2,247,060
145
-15,497
VP, Corp. Controller & CAO
2022-10-26
DEPPE MICHAEL J
ACQUIRED
833,598
53.7909
15,497
VP, Corp. Controller & CAO
2022-10-19
Gregg Vicky B
ACQUIRED
9,447.36
127.667
74
-
2022-09-01
RING TIMOTHY M
SOLD
-250,040
125.02
-2,000
-
2022-09-01
RING TIMOTHY M
ACQUIRED
122,450
61.225
2,000
-

1–10 of 50

Stephen H. Rusckowski
49000
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DGX Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net revenues$ 2,486$ 2,774$ 7,550$ 8,044
Operating costs and expenses and other operating income:    
Cost of services1,6181,6704,8754,861
Selling, general and administrative4644271,3111,263
Amortization of intangible assets27258177
Other operating income, net(15)0(10)(2)
Total operating costs and expenses, net2,0942,1226,2576,199
Operating income3926521,2931,845
Other income (expense):    
Interest expense, net(33)(38)(106)(114)
Other (expense) income, net(8)40(61)366
Total non-operating (expense) income, net(41)2(167)252
Income before income taxes and equity in earnings of equity method investees3516541,1262,097
Income tax expense(81)(153)(268)(483)
Equity in earnings of equity method investees, net of taxes6264153
Net income2765278991,667
Less: Net income attributable to noncontrolling interests20225462
Net income attributable to Quest Diagnostics$ 256$ 505$ 845$ 1,605
Earnings per share attributable to Quest Diagnostics’ common stockholders:    
Basic (in dollars per share)$ 2.20$ 4.11$ 7.17$ 12.63
Diluted (in dollars per share)$ 2.17$ 4.02$ 7.05$ 12.41
Basic (in Shares)116123117127
Diluted (in Shares)118125119129

DGX Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets  
Cash and cash equivalents$ 700$ 872
Accounts receivable, net of allowance for credit losses of $29 and $31 as of September 30, 2022 and December 31, 2021, respectively1,2801,438
Inventories183208
Prepaid expenses and other current assets171223
Total current assets2,3342,741
Property, plant and equipment, net1,7071,707
Operating lease right-of-use assets607597
Goodwill7,1907,095
Intangible assets, net1,1151,167
Investments in equity method investees138141
Other assets132163
Total assets13,22313,611
Liabilities and Stockholders' Equity  
Accounts payable and accrued expenses1,4471,600
Current portion of long-term debt22
Current portion of long-term operating lease liabilities153151
Total current liabilities1,6021,753
Long-term debt3,9804,010
Long-term operating lease liabilities505494
Other liabilities787792
Commitments and contingencies
Redeemable noncontrolling interest7779
Quest Diagnostics stockholders’ equity:  
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2022 and December 31, 2021; 162 shares issued as of both September 30, 2022 and December 31, 202122
Additional paid-in capital2,2722,260
Retained earnings8,2637,649
Accumulated other comprehensive loss(31)(14)
Treasury stock, at cost; 48 and 43 shares as of September 30, 2022 and December 31, 2021, respectively(4,271)(3,453)
Total Quest Diagnostics stockholders' equity6,2356,444
Noncontrolling interests3739
Total stockholders' equity6,2726,483
Total liabilities and stockholders' equity$ 13,223$ 13,611